Liraglutide or Victoza – How This Harmful Drug Affects People with Type 2 Diabetes

A drug may be helpful or harmful. Learning the facts about drugs can help you see the risks of chasing this excitement or escape. Here’s what you need to know about Liraglutide (Victoza). Liraglutide is a long acting glucagon-like peptide-1 agonist logo_victoza_600x252medication. The drug has been marketed as Victoza and it belongs to the group of incretin mimetics. Liraglutide in its Victoza form is administered as a subcutaneous injection of the abdomen, thigh or arm and it is used to treat people who have type 2 diabetes and who are not able to control their blood sugar levels with oral medicines. This drug is manufactured by Novo Nordisk.

Continue reading